Related Experiment Video
Updated: Jun 21, 2026

Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
Immunologically mediated dementias
Michael H Rosenbloom1, Sallie Smith, Gulden Akdal
1UCSF Memory and Aging Center, Box 1207, San Francisco, CA 94143, USA. michael.geschwind@ucsf.edu
Abstract:
Although most dementias are due to neurodegenerative or vascular disease, it is important to diagnose immunologically mediated dementias quickly because they can be both rapidly progressive and readily treatable. They usually affect function of limbic and cortical structures, but subcortical involvement can also occur. Because of the variety of symptoms and the rapid course, these dementias present a particular challenge to the clinician and may require evaluation and intervention in the inpatient setting. Diagnostic workup typically reveals evidence of an autoimmune process and, in some cases, cancer. In contrast to the neurodegenerative processes, many of the immunologically mediated dementias respond to immunomodulatory therapy.
More Related Videos
Related Concept Videos
Dementia l: Introduction
Encephalitis l: Introduction
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Alzheimer Disease l: Introduction
Encephalitis ll: Pathophysiology
Dementia
The progression of dementia is generally gradual.

